Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway
Open accessThe DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
Abstract
Numerous studies have now shown that the amyloid beta-protein (Abeta), the principal component of cerebral plaques in Alzheimer disease, rapidly and potently inhibits certain forms of synaptic plasticity. The amyloid (or Abeta) hypothesis proposes that the continuous disruption of normal synaptic physiology by Abeta contributes to the development of Alzheimer disease. However, there is little consensus about how Abeta mediates this inhibition at the molecular level. Using mouse primary hippocampal neurons, we observed that a brief treatment with cell-derived, soluble, human Abeta disrupted the activation of three kinases (Erk/MAPK, CaMKII, and the phosphatidylinositol 3-kinase-activated protein Akt/protein kinase B) that are required for long term potentiation, whereas two other kinases (protein kinase A and protein kinase C) were stimulated normally. An antagonist of the insulin receptor family of tyrosine kinases was found to mimic the pattern of Abeta-mediated kinase inhibition. We then found that soluble Abeta binds to the insulin receptor and interferes with its insulin-induced autophosphorylation. Taken together, these data demonstrate that physiologically relevant levels of naturally secreted Abeta interfere with insulin receptor function in hippocampal neurons and prevent the rapid activation of specific kinases required for long term potentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If Akt is not phosphorylated, GSK3-β remains active [93] and is described as responsible for events related to AD pathology, including the hyperphosphorylation of Tau [94].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAlzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Self-citationDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Mechanism of activation of protein kinase B by insulin and IGF-1.
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,004
Long-Term Potentiation and Memory
LYNCH, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 1,991
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Self-citationShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Self-citationRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene
Montminy, M. R., & Bilezikjian, L. M. (1987) · Nature · doi:10.1038/328175a0 · Cited by 1,357
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Cited by
Items 201–300 of 321
Simvastatin Treatment Preserves Synaptic Plasticity in AβPPswe/PS1dE9 Mice
Métais, C., Brennan, K., Mably, A. J., Scott, M., Walsh, D. M., & Herron, C. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130257 · Cited by 27
Effects of glucose and insulin on secretion of amyloid‐β by human adipose tissue cells
Tharp, W. G., Gupta, D., Smith, J. S., Jones, K. P., Jones, A. M., & Pratley, R. E. (2016) · Obesity · doi:10.1002/oby.21494 · Cited by 27
“This competition reduces signal transduction through the insulin receptor signaling pathway and prolongs the half-lives of both Ab and insulin (32,33).”
BackgroundWare, E. B., Morataya, C., Fu, M., & Bakulski, K. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.634767 · Cited by 27
“While there are several potential mechanisms to support such findings (Gasparini et al., 2001; Townsend et al., 2007), it is unclear whether and how these two conditions are causally linked.”
BackgroundMurakami, K., Yokoyama, S.-I., Murata, N., Ozawa, Y., Irie, K., Shirasawa, T., & Shimizu, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.101 · Cited by 26
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase
Wee, A. S., Nhu, T. D., Khaw, K. Y., Tang, K. S., & Yeong, K. Y. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21999221111102343 · Cited by 25
“Additionally, Aβ and insulin are competing for insulin receptors and degradation by IDE, which probably reduces signal transduction through the insulin receptor signaling pathway and prolongs Aβ half-life [59, 60].”
BackgroundAlzheimer disease: update on basic mechanisms.
Bi, X. (2010) · PubMed · Cited by 40
Microtubule Depolymerization and Tau Phosphorylation
Hernández, F., García‐García, E., & Ávila, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130545 · Cited by 26
Brain amyloid β protein and memory disruption in Alzheimer’s disease
Xia, W. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s7460 · Cited by 28
“by an antagonist of the insulin receptor family of tyrosine kinases.(55)”
Patricio-Martínez, A., Patricio, F., Macuil-Chapuli, E., Martínez-Juárez, E. Á., Flores-Díaz, S., Cedillo-Ramirez, M. L., & Limón, I. D. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1598011 · Cited by 28
Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Alkadhi, K. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376307 · Cited by 23
“Furthermore, the presence of abnormal levels of A peptides disrupts phosphorylation of CaMKII and interferes with LTP induction, as reported in both in vivo and in vitro studies [19, 93, 94].”
Ge, Y., Zeng, F., Sun, G., Peng, K., Li, X., Yu, H., Cheng, C., Xu, Y., & Yang, J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00419 · Cited by 25
Kwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 25
Fitzgerald, G. S., Chuchta, T. G., & McNay, E. C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14160 · Cited by 22
β‐Amyloid 1‐42 induces physiological transcriptional regulation of BACE1
Piccini, A., Borghi, R., Guglielmotto, M., Tamagno, E., Cirmena, G., Garuti, A., Pollero, V., Cammarata, S., Fornaro, M., Messa, M., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07834.x · Cited by 22
“2009), insulin receptor (Townsend et al. 2007), acetylcholine receptors (Parri and Dineley 2010), leading to signaling cascades that involve the MAPK pathway, NFKB, and more, possibly controlling gene expression.”
BackgroundPeripheral Aβ acts as a negative modulator of insulin secretion
Shigemori, K., Nomura, S., Umeda, T., Takeda, S., & Tomiyama, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117723119 · Cited by 23
Han, X., Ma, Y., Liu, X., Wang, L., Qi, S., Zhang, Q., & Du, Y. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0803-1 · Cited by 20
Recent developments in the chemical biology of amyloid-β oligomer targeting
Wang, Y., Chen, J., Gao, F., Hu, M., & Wang, X. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob00509g · Cited by 21
Bagheri‐Mohammadi, S., Askari, S., Alani, B., Moosavi, M., & Ghasemi, R. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02075-x · Cited by 19
Bartl, J., Meyer, A. H., Brendler, S., Riederer, P., & Grünblatt, E. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0852-5 · Cited by 21
“It was already shown that Ab42 oligomers interact with neuronal INSR to cause impairments of the receptor expression and function (Townsend et al. 2007; Zhao et al. 2009).”
BackgroundLiang, J., Kulasiri, D., & Samarasinghe, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182743 · Cited by 19
Modulating Metals As A Therapeutic Strategy For Alzheimer’s Disease
Hung, L. W., & Barnham, K. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.32 · Cited by 20
Chronic psychosocial stress exposes Alzheimer s disease phenotype in a novel at-risk model
Karim, A. A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/371 · Cited by 19
Keowkase, R., Aboukhatwa, M. A., Adam, B.-L., Beach, J. W., Terry, A. V., Buccafussco, J. J., & Luo, Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-59 · Cited by 19
“Significant evidence indicates that insulin receptor/IGF-1 receptor signaling plays a role in AD [34] and has direct effect on the metabolism and clearance of Ab [35,36].”
BackgroundSui, H., Zhang, L., Liu, Z., & Jin, Y. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.161 · Cited by 17
Kim, J., Roh, Y.-J., Choi, Y., Lee, S., Jin, Y.-J., Song, H.-J., Seol, A., Son, H., Hong, J. T., & Hwang, D. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314928 · Cited by 17
Ávila, J., de Barreda, E. G., Pallas‐Bazarra, N., & Hernández, F. (2013) · Europe PMC (PubMed Central) · doi:10.13039/501100006373 · Cited by 25
Lü, C., Shi, Z., Sun, X., Pan, R., Chen, S., Li, Y., Qu, L., Sun, L., Dang, H., Bu, L.-L., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.002 · Cited by 17
“clearly demonstrated that soluble Aβ1-40 disrupted the activation of ERK (Townsend et al., 2007), CaMKII (Zhao et al.”
BackgroundResultBasic mechanisms of plasticity and learning
Mancini, A., de Iure, A., & Picconi, B. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00002-3 · Cited by 20
Wu, X., Kosaraju, J., Zhou, W., & Tam, K. Y. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.003 · Cited by 16
“Aggregation of Ab has been reported to enable the hyperphosphorylation of tau by GSK-3b (Magdesian et al., 2008; Townsend et al., 2007).”
BackgroundGupta, S. N., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666181114163515 · Cited by 16
Nonesterified fatty acids, cognitive decline, and dementia
Mukamal, K. J. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000656 · Cited by 16
“In mouse hippocampi, bamyloid binds to the insulin receptor and disrupts insulin signaling [22].”
BackgroundYong, J., & Song, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116688 · Cited by 15
Hooshmandi, E., Moosavi, M., Katinger, H. W. D., Sardab, S., Ghasemi, R., & Maghsoudi, N. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05309-6 · Cited by 16
Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
Flynn, C. M., & Yuan, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1159314 · Cited by 15
“It is also known that Aβ-facilitated tau phosphorylation by GSK-3 pathways can be mediated through the interference with insulin or wnt pathways (Townsend et al., 2007; Magdesian et al., 2008).”
BackgroundLibeu, C. P., Descamps, O., Zhang, Q., John, V., & Bredesen, D. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040027 · Cited by 16
“Recent, complementary results argue that signaling events, some of which are mediated by the amyloid precursor protein (APP) itself, also play a crucial role in the development of the AD phenotype [2,9,10,11,12,13].”
BackgroundAlkadhi, K. A., & Tran, T. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8839-x · Cited by 16
A critical overview of therapeutic strategy and advancement for Alzheimer's disease treatment
Kuo, Y., & Rajesh, R. (2017) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2017.05.011 · Cited by 18
Liu, X., Teng, Z., Cui, C., Wang, R., Liu, M., & Zhang, Y. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0216-0 · Cited by 16
“If this balance is disrupted, soluble Aβ may competitively combine with IRs and interfere with autophosphorylation of these receptors (Townsend et al. 2007).”
Zhou, A. L., Swaminathan, S. K., Salian, V. S., Wang, L., Curran, G. L., Min, H.-K. P., Lowe, V. J., & Kandimalla, K. K. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00784 · Cited by 14
Ayan, E. B., & DeMirci, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 15
O’Reilly, L. P., Benson, J. A., Cummings, E. E., Perlmutter, D. H., Silverman, G. A., & Pak, S. C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.930125 · Cited by 16
“These studies provide further evidence for the close association of IIS and proteostasis [110-113] and suggest that modulators of IIS and neuroendocrine signaling may be useful strategies for treating conformational diseases.”
BackgroundChan, E. S., Chen, C., Soong, T. W., & Wong, B. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8480-3 · Cited by 14
Shi, W., Wu, H., Liu, S., Wu, Z., Wu, H., Liu, J., & Yan-ning, H. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.020 · Cited by 15
Soluble Oligomers of the Amyloid β-Protein: Impair Synaptic Plasticity and Behavior
Selkoe, D. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-76330-7_8 · Cited by 18
Self-citationExercise with 40-Hz light flicker improves hippocampal insulin signaling in Alzheimer disease mice
Kim, S.-H., Park, S.-S., Kim, C., & Kim, T.-W. (2022) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2244042.021 · Cited by 13
“GSK-3 is blocked by GSK3α or GSK3β phosphorylation of Ser 21 or Ser 9 and is enhanced in the lack of Akt activation (Townsend et al., 2007).”
BackgroundChoquet, D., Opazo, P., & Zhang, H. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00470-z · Cited by 13
Wang, X., Song, X., Takata, T., Miichi, Y., Yokono, K., & Sakurai, T. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.07.004 · Cited by 12
Association of Alzheimer’s Disease and Insulin Resistance in King Abdulaziz Medical City, Jeddah
Faqih, N. T., Ashoor, A. F., Alshaikh, S. A., Maglan, A., & Jastaniah, N. A. (2021) · Cureus · doi:10.7759/cureus.19811 · Cited by 16
Harun, Z. Z., Azhar, A. A., Kim, Y. J., Ibrahim, F. W., Ng, M. H., Tan, J. K., & Lokanathan, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13122931 · Cited by 11
Combes, M., Poindron, P., & Callizot, N. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23524 · Cited by 12
“Soluble Ab binds to insulin receptor, altering its autophosphorylation; then, it interferes with receptor functions in hippocampal neurons, preventing rapid activation of specific kinases involved in the long-term potentiation (Townsend et al., 2007).”
BackgroundKhodabakhsh, P., Bazrgar, M., Mohagheghi, F., Parvardeh, S., & Ahmadiani, A. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13980 · Cited by 11
Gain of function by phosphorylation in Presenilin 1‐mediated regulation of insulin signaling
Maesako, M., Uemura, K., Kuzuya, A., Sasaki, K., Asada, M., Watanabe, K., Andō, K., Kubota, M., Akiyama, H., Takahashi, R., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07741.x · Cited by 11
“Several reports have already demonstrated the physiological relationship between IR and Ab in vitro (Townsend et al. 2007; Zhao et al. 2008).”
BackgroundInsulin regulates Presenilin 1 localization via PI3K/Akt signaling
Maesako, M., Uemura, K., Kubota, M., Ando, K., Kuzuya, A., Asada, M., Kihara, T., & Kinoshita, A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.055 · Cited by 12
“Since several reports suggest that A oligomers play an important role on insulin signaling [26-28], we assume”
BackgroundEpigenetic control of somatostatin and cortistatin expression by β amyloid peptide
Rubio, A., Sanchez-Mut, J. V., García, E., Velásquez, Z. D., Cruz, J. O. L., Esteller, M., & Ávila, J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22731 · Cited by 13
“One of these intracellular signals is an increase in GSK3 activity (Townsend et al., 2007; Magdesian et al., 2008).”
BackgroundShen, W., Elahi, M., Wang, B., Zhan, M., Yang, P., & Yang, P. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215687 · Cited by 10
Cerebellar Insulin/IGF-1 signaling in diabetic rats: Effects of exercise training
Borges, M. E., Ribeiro, A. M., Pauli, J. R., Arantes, L. M., Luciano, E., de Moura, L. P., Leme, J. A. C. D. A., Medeiros, A., Bertolini, N. O., Sibuya, C. Y., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.059 · Cited by 10
Shi, Z., Lü, C., Sun, X., Wang, Q., Chen, S., Li, Y., Qu, L., Chen, L., Bu, L.-L., Liao, D., et al. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0584-9 · Cited by 11
“Moreover, substantial evidence demonstrates that multiple neurotransmitters, cell surface protein receptors and intracellular signal transductions, including acetylcholine (Ach), glutamate (Glu), muscarinic acetylcholine receptors (mAChR), N-methyl-D-aspartic acid (NMDA) receptors, extracellular signal-regulated kinas…”
ResultInfluentialBeta-amyloid oligomers: recent developments
Borutaite, V., Morkuniene, R., & Valincius, G. (2011) · bmc · doi:10.1515/bmc.2011.019 · Cited by 9
“However, there are several studies suggesting apoptosis to be induced by Ab oligomers (94, 96, 119, 120, 131).”
BackgroundQuerfurth, H., Marshall, J., Parang, K., Rioult-Pedotti, M. S., Tiwari, R., Kwon, B., Reisinger, S., & Lee, H.-K. (2022) · PLOS ONE · doi:10.1371/journal.pone.0261696 · Cited by 9
“Hippocampal LTP is particularly sensitive to Aβ oligomers [48, 49].”
BackgroundNeuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 11
The Role of Insulin Dysregulation in Aging and Alzheimer’s Disease
Craft, S. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_8 · Cited by 9
Sonkar, V. K., Kulkarni, P. P., Chaurasia, S. N., Dash, A., Jauhari, A., Parmar, D., Yadav, S., & Dash, D. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00003 · Cited by 9
The mTOR Signaling Pathway in Neurodegenerative Diseases
Francois, A., Vérité, J., Bilan, A. R., Janet, T., Calon, F., Fauconneau, B., Paccalin, M., & Page, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00011-6 · Cited by 9
Exploring the Diverse Roles of GSK-3β Kinase in Alzheimer’s Disease
Shareena, G., Kumar, D., & Thorat, N. D. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_11 · Cited by 10
The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
Medina, M., & Avil, J. (2011) · InTech eBooks · doi:10.5772/16879 · Cited by 7
Miichi, Y., Sakurai, T., Akisaki, T., & Yokono, K. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00712.x · Cited by 8
Functional neuroanatomy and disorders of cognition
Nakhate, K. T., Borkar, C. D., & Bharne, A. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819445-4.00002-3 · Cited by 10
Tau Kinase I Overexpression Induces Dentate Gyrus Degeneration
Ávila, J., de Barreda, E. G., Engel, T., Pérez, M., Martín-Maestro, P., Fuster-Matanzo, A., Goñi‐Oliver, P., Lucas, J. J., & Hernández, F. (2010) · Neurodegenerative Diseases · doi:10.1159/000283476 · Cited by 7
The Role of Glycogen Synthase Kinase 3 in the Mechanisms of Learning and Memory
Grigoryan, G. A. (2014) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-014-0023-2 · Cited by 6
“It is known that betaamyloid can alter GSK-3b activity [83], though the kinase itself influences the degradation of beta-amyloid.”
BackgroundImpaired Glucose Metabolism in Alzheimer’s Disease and Diabetes
Mushtaq, G. (2014) · Enzyme Engineering · doi:10.4172/2329-6674.1000124 · Cited by 9
Metabolic Syndrome as a Risk Factor for Alzheimer Disease
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_8 · Cited by 5
Glucose Metabolism, Insulin, and Aging
Boemi, M., Furlan, G., & Luconi, M. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00029-7 · Cited by 8
Yang, H., Li, X., Yang, W., Feng, S., & Ma, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0846-6 · Cited by 4
Khadgawat, P., Siddesha, J. M., Shashank, D., & Shashanka, K. P. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210018 · Cited by 5
“The A plaques hinder both insulin [28] and Wnt signaling pathways [29], creating an abundance of activated GSK3 in the neuronal cells.”
BackgroundRisk Factors for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00002-1 · Cited by 4
BACE1 at the crossroads of a vicious circle between Alzheimer’s disease and diabetes mellitus
Ohno, M. (2025) · Frontiers in Dementia · doi:10.3389/frdem.2025.1730524 · Cited by 5
Liu, J., Peng, F., Li, P., Yao, C., Jin, S., Wu, G., Zhang, T., Liang, Q., Wang, X., & Du, X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03525-3 · Cited by 3
“…mechanism underlying CBD ’ s disease-modifying effects, our fi ndings highlight the FRS2 – TrkB interface as a promising therapeutic target and provide a conceptual framework for the rational design of next-generation TrkB modulators for Alzheimer ’ s disease and related neurodegenerative disorders.”
Role of Glycogen Synthase Kinase-3 in Mechanisms of Learning and Memory
Grigoryan, G. A. (2013) · Журнал высшей нервной деятельности им И П Павлова · doi:10.7868/s0044467713050043 · Cited by 3
Animal Models of Alzheimer’s Disease
Kiyota, T. (2013) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4614-8794-4_35 · Cited by 3
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 11
Misfolded Proteins in Neurodegenerative Dementias: Molecular Mechanisms
Yang, H. D., Ho, D. H., Yi, M. J., Seol, W., & Kim, S. (2012) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2012.11.2.38 · Cited by 2
Amyloid Hypothesis: Molecular and Cellular Aspects of Toxicity
Kayed, R., & Lasagna‐Reeves, C. A. (2013) · Modecular medicine and medicinal · doi:10.1142/9781848167551_0001 · Cited by 3
“Townsend et al. (2007) found that soluble Aβ binds to IR and”
BackgroundÁvila, J., & Hernández, F. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_3 · Cited by 2
Biological Targeting and Activity of Pre-fibrillar Aβ Assemblies
Wilcox, K. C., Pitt, J. E., Sebollela, A. S., Martirosova, H., Lacor, P. N., & Klein, W. L. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_4 · Cited by 1
Ávila, J. (2011) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000102e · Cited by 1
“In familiar AD, mutations in the app, ps-1 or ps-2 genes promote disease onset [8], and while this may be dependent [9,10] or independent [11-13] of increases in beta amyloid peptide, GSK3 activation augments in both scenarios.”
BackgroundA Novel Preclinical Rat Model of Alzheimer’s Disease
Alkadhi, K. A. (2019) · Neuromethods · doi:10.1007/978-1-4939-9944-6_4 · Cited by 1
Insulin resistance and Alzheimer’s disease
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00006-7 · Cited by 1
Effects of Long Term Consumption of High Calorie Diet on Neurological Disorders
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_9 · Cited by 1
Polymeric nanoparticles as original theranostic approach for alzheimer‟s disease
Brambilla, D. (2012) · theses.fr (ABES) · doi:10.70675/d21b5d1ez6c2dz410dzb9baz0637e40e2fa2 · Cited by 1
Rôle du peptide amyloïde dans les maladies neurodégénératives
Combes, M. (2018) · theses.fr (ABES) · doi:10.70675/a219ef4dzbca0z4272z8bf2z74080a1976e5 · Cited by 1
Chen, C. (2014) · UKnowledge (University of Kentucky)
The Janus Face of Insulin in Brain
Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Plácido, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch5 · Cited by 1
Modulation of Cognition by Insulin and Aging: Implications for Alzheimer Disease
Solas, M., & Ramírez, M. J. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch6
Characterisation of transgenic mouse models of Alzheimer's disease
Graham, L. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Estrogen-induced Signaling Links Structural and Functional Synaptic Plasticity
Logan, S. M. (2009) · Digital Commons @ UNT Health Science Center
Synaptic elimination and the complement system in Alzhaimer's disease
Daborg, J. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
da Silva, T. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Señalización por insulina en el cerebro y su participación en la enfermedad de Alzheimer
Heras-Sandoval, D., & Arias, C. (2009) · Cited by 1
Liu, J., Peng, Y., & Long, J. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00275
dos Santos, A. C. F., & dos Santos (2012)
Metadata
- Authors
- Townsend, M., Mehta, T., & Selkoe, D. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Selkoe, Dennis J.
- ORCID
- Selkoe, Dennis J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 282
- Issue
- 46
- Pages
- 33305-33312
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2058581619
- Cited by
- 318
- References
- 55
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 15 · 2021: 6 · 2020: 13 · 2019: 9 · 2018: 12 · 2017: 14 · 2016: 26 · 2015: 19 · 2014: 22 · 2013: 26 · 2012: 40
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4724 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG027443, R01AG027443)
- National Institute of Neurological Disorders and Stroke (T32 NS07484-04, T32NS007484)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, insulin receptor, signal transduction, long-term potentiation, ERK MAPK, CaMKII, Akt/protein kinase B, phosphatidylinositol 3-kinase, protein kinase A, protein kinase C, kinase autophosphorylation, hippocampal neurons, Alzheimer's disease, amyloid hypothesis, synaptic plasticity
- MeSH terms
- Animals, Cricetulus, Electrophysiology, Enzyme Activation, Cricetinae, Hippocampus, Humans, Insulin, Models, Biological, Phosphorylation, Receptor, Insulin, Signal Transduction, Amyloid beta-Peptides, CHO Cells, Long-Term Potentiation, Phosphatidylinositol 3-Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.